Indirect protection obtained by Haemophilus influenzae type b vaccination: analysis in a structured population model
暂无分享,去创建一个
K. Auranen | P. Mäkelä | A. Takala | T. Leino | T. Takala
[1] K. Auranen,et al. Modelling transmission, immunity and disease of Haemophilus influenzae type b in a structured population , 2004, Epidemiology and Infection.
[2] K. Auranen,et al. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. , 2003, Vaccine.
[3] M. Ramsay,et al. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. , 2003, Communicable disease and public health.
[4] M. Steinhoff,et al. Conjugate Hib vaccines , 2003, The Lancet.
[5] K. Auranen,et al. Haemophilus influenzae type b and cross-reactive antigens in natural Hib infection dynamics; modelling in two populations , 2002, Epidemiology and Infection.
[6] Elja Arjas,et al. Transmission of Pneumococcal Carriage in Families: A Latent Markov Process Model for Binary Longitudinal Data , 2000 .
[7] J. Deeks,et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. , 2000, JAMA.
[8] S. Romero-Steiner,et al. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. , 2000, The Journal of infectious diseases.
[9] R. Singleton,et al. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage. , 2000, The Journal of pediatrics.
[10] M. Santosham. Can Haemophilus influenzae type b disease be eliminated from the United States? , 2000, The Journal of pediatrics.
[11] G. Garnett,et al. The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease , 1999, Epidemiology and Infection.
[12] G. Garnett,et al. Mathematical models of Haemophilus influenzae type b , 1998, Epidemiology and Infection.
[13] S. Jaffar,et al. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. , 1998, The Journal of infectious diseases.
[14] Rosanna Lagos,et al. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens , 1998, The Lancet.
[15] A. van der Ende,et al. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity. , 1997, The Journal of pediatrics.
[16] D. Crook,et al. Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T , 1997, Archives of disease in childhood.
[17] E. Moxon,et al. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster , 1997, The Lancet.
[18] M. Barbour,et al. Conjugate vaccines and the carriage of Haemophilus influenzae type b. , 1996, Emerging infectious diseases.
[19] P. Mäkelä,et al. Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. , 1996, The Journal of pediatrics.
[20] J. van Marle,et al. Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication , 1996, Infection and immunity.
[21] J. Eskola,et al. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. , 1995, The Pediatric infectious disease journal.
[22] D. Crook,et al. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. , 1995, The Journal of infectious diseases.
[23] P. Mäkelä,et al. Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy. , 1994, Archives of pediatrics & adolescent medicine.
[24] G. W. Letson,et al. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants , 1993, The Pediatric infectious disease journal.
[25] H. Chapel,et al. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b. , 1993, BMJ.
[26] R. Belshe,et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. , 1992, The Journal of pediatrics.
[27] K. Edwards,et al. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. , 1992, The Journal of pediatrics.
[28] M. Leinonen,et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. , 1991, The Journal of infectious diseases.
[29] P. Mäkelä,et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. , 1990, The New England journal of medicine.
[30] H. Valkenburg,et al. Carriage of Haemophilus influenzae in healthy Gambian children. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[31] Denis Mollison,et al. The Analysis of Infectious Disease Data. , 1989 .
[32] P. Mäkelä,et al. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. , 1989, The Pediatric infectious disease journal.
[33] E. Moxon,et al. Meningitis caused by Haemophilus influenzae in infant rats: protective immunity and antibody priming by gastrointestinal colonization with Escherichia coli. , 1979, The Journal of infectious diseases.
[34] C. Norden,et al. Pharyngeal colonization with Haemophilus influenzae type b: a longitudinal study of families with a child with meningitis or epiglottitis due to H. influenzae type b. , 1977, The Journal of infectious diseases.
[35] J. C. Parke,et al. Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b. , 1971, Lancet.